NEW YORK ( TheStreet) -- LHC Group (Nasdaq: LHCG) has been downgraded by TheStreet Ratings from hold to sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share.

Highlights from the ratings report include:
  • The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Health Care Providers & Services industry. The net income has significantly decreased by 385.5% when compared to the same quarter one year ago, falling from $13.30 million to -$37.96 million.
  • Return on equity has greatly decreased when compared to its ROE from the same quarter one year prior. This is a signal of major weakness within the corporation. Compared to other companies in the Health Care Providers & Services industry and the overall market, LHC GROUP INC's return on equity significantly trails that of both the industry average and the S&P 500.
  • Net operating cash flow has significantly decreased to -$49.41 million or 390.59% when compared to the same quarter last year. In addition, when comparing to the industry average, the firm's growth rate is much lower.
  • Despite any intermediate fluctuations, we have only bad news to report on this stock's performance over the last year: it has tumbled by 44.22%, worse than the S&P 500's performance. Consistent with the plunge in the stock price, the company's earnings per share are down 384.93% compared to the year-earlier quarter. Naturally, the overall market trend is bound to be a significant factor. However, in one sense, the stock's sharp decline last year is a positive for future investors, making it cheaper (in proportion to its earnings over the past year) than most other stocks in its industry. But due to other concerns, we feel the stock is still not a good buy right now.
  • LHC GROUP INC has exprienced a steep decline in earnings per share in the most recent quarter in comparison to its performance from the same quarter a year ago. This company has reported somewhat volatile earnings recently. We feel it is likely to report a decline in earnings in the coming year. During the past fiscal year, LHC GROUP INC increased its bottom line by earning $2.68 versus $2.43 in the prior year. For the next year, the market is expecting a contraction of 17.9% in earnings ($2.20 versus $2.68).

LHC Group, Inc., through its subsidiaries, provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the United States. The company has a P/E ratio of 6.7, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. LHC Group has a market cap of $289 million and is part of the health care sector and health services industry. Shares are down 48.9% year to date as of the close of trading on Thursday.

You can view the full LHC Group Ratings Report or get investment ideas from our investment research center.
null

If you liked this article you might like

These 6 Healthcare Stocks Are Set to Be Tops in Their Field, Jefferies Says

Insider Trading Alert - LHCG, IPHS And TLGT Traded By Insiders

Insider Trading Alert - IT, NHTC And LHCG Traded By Insiders

Insider Trading Alert - BXMT, LHCG And BABY Traded By Insiders

Insider Trading Alert - COBZ, RMCF And LHCG Traded By Insiders